“Ten-Year Response to Crizotinib in ALK-Positive Inflammatory Myofibroblastic Tumors: Case Reports”. 2024. Voprosy Onkologii 70 (2): 384-89. https://doi.org/10.37469/0507-3758-2024-70-2-384-389.